On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of US $112 million in the US
Revenue from operations up 26% to Rs. 768 crores
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
Hello Patients provides healthcare billing and patients’ management solution
Subscribe To Our Newsletter & Stay Updated
